NEW YORK, Dec. 14, 2016 -- Dr. Carlos Encarnacion, Physician at Texas Oncology, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in Medical Oncology and Hematology and Cancer Genetics.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1935bcff-f4bf-472b-8836-d6c7ca54f754
Dr. Encarnacion has been active in the healthcare industry for the past 23 years and specifically 20 years at Texas Oncology. He obtained his MD from the University of Puerto Rico School of Medicine in 1986 and completed his Fellowship in Oncology from the University of Texas Health Science Center at San Antonio in 1993.
Texas Oncology, a statewide physician-led practice, conducts innovative research and delivers leading-edge technology and treatment options. Founders of the practice pioneered community-based care to enable more cancer patients to receive high-quality care while staying close to the critical support of family and friends.
Dr. Encarnacion’s day-to-day responsibilities include treating all forms of cancer, with a specialty in breast cancer. He is the area Medical Director, oversees the local Clinical Genetic Program, and serves as Site Research Leader. He also chairs the Cancer Committee at Providence Health Center.
Dr. Encarnacion attributes his success to his interaction with his patients and enjoys working with an excellent crew of dedicated professionals. His long-term goals include improving cancer awareness in the local community and continued upward movement through the research program within his network.
Dr. Encarnacion’s many awards and honors include: Dean’s List, University of Puerto Rico; Alpha-Omega-Alpha Honor Medical Society; Certificate of Merit, University of Puerto Rico School of Medicine; Scientific Research Award, ACP Puerto Rico Chapter; American Cancer Society Fellowship; Ciba-Geigy Fellowship Grant, Katherine Wood Johnson Travel Award; Upjohn Travel Award; Fellow, American College of Physicians; and Friend of the ACS Award. He has been a speaker for the American Cancer Society, Providence Cancer Program, and Texas Oncology in multiple venues.
Dr. Encarnacion is affiliated with the American College of Physicians, Texas Medical Association, McLennan County Medical Society, and American Society of Clinical Oncology, as well as the non-profit organization Commemorative Air Force (CAF).
In his free time, Dr. Encarnacion enjoys working out, beekeeping, and flying.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Instagram Outage Disrupts Thousands of U.S. Users
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



